Introduction
Genomewide association studies (GWAS) were designed to identify the common genetic etiologies of heritable traits and disorders. Thus far, most of the reported associations account for only a small fraction of the genetic effects that were anticipated from previous heritability estimates. 1 This is particularly true for neuropsychiatric disorders. One plausible explanation is that, such genetically complex traits and disorders result from a larger number of predisposing variants with smaller effect sizes than was previously anticipated, making the variants difficult to detect statistically. 2 An added limitation may be that other risk factors (F), including those in the environment or from interactions with other genes, have not been considered by most GWAS.
That is, ignoring additional F, makes association studies less precise and reduces their statistical power, particularly if there is an interaction (G Â F) between the gene variant being tested, G, and F. The hallmark of a G Â F is a differential association of G with the disorder under analysis, contingent upon F. For example, a lung cancer predisposing allele may elevate the baseline risk of G threefold in smokers, but provide only a small or negligible elevation of the risk in nonsmokers. That is, G is a genetic risk factor only in the presence smoking, and if F is not incorporated into the association analysis, the power to detect G can be substantially reduced, allowing G to remain undetected in a mixed study sample of smokers and nonsmokers. Although investigators recognize the importance of including F and G Â F in a GWAS, implementation has been rare. This reflects three realities; (1) the lack of consistently collected environmental F in the very large GWAS case and control samples currently under investigation, (2) a lack of insight into the essential environmental F for many neurobehavioral disorders and (3) the daunting task of reducing the potential gene-gene interactions to a manageable set.
If relevant data are available for a case and control sample, logistic regression is often used to test G for association with a disorder, and these regression models can easily be extended to include F and G Â F. Joint tests are defined by the simultaneous statistical test of two or more factors, F and G Â F, in a single analysis. The value of this approach has been made explicit by Kraft et al., 3 who presented a power analysis of joint tests for a simulated case and control sample, in which they demonstrated that joint tests boost the statistical power to identify G under a wide variety of disease risk models. As the study sample becomes more complex to include parent/child trios or multiplex nuclear families, however, the application of logistic regression and joint tests of association is not straightforward. For family data, the transmission disequilibrium test 4 has often been used to assess the association of a single nucleotide polymorphism (SNP) and a disorder in parent/affected child trios and the Family Based Association Test (FBAT) 5 has been employed to conduct the analysis in multiplex families. Both tests count alleles transmitted to the affected child and the observed proportion of transmitted alleles is compared with what is expected, and these analyses do not readily allow one to include F or conduct joint tests. However, joint tests can be implemented when the case/pseudocontrol approach proposed by Cordell et al. 6, 7 is applied, as it generalizes the transmission disequilibrium test to permit the inclusion of these additional factors.
Joint tests were conducted genomewide to detect novel G and G Â F for Autism spectrum disorder (ASD). This is a neurobehavioral phenotype that strikes one in every 150 children and one in 100 males. Its early childhood onset is characterized by deficits in social interactions and language development, and the presence of stereotypic restricted and repetitive behaviors. 8 Although twin and family aggregation studies indicate ASD has a substantial genetic etiology, 9 linkage and association studies reinforce the fact that it is genetically complex. GWAS have been conducted with few genomewide significant associations, [10] [11] [12] and current investigations have become focused on identifying rare and highly penetrant sequence and copy-number variants. 13 ASD is well suited for joint tests of G and G Â F, as it is four times more frequent in males than in females. 14 This difference in ASD prevalence may result in part from the differential penetrance of some risk alleles on the basis of the sex of the affected individual. In this analytic approach, sex can be viewed as an F, where being male may allow certain predisposing alleles to be more penetrant than they are in females. Evidence supporting the differential penetrance of alleles on the basis of sex in ASD is seen on Chromosome 17 in previous affected sibling-pair linkage studies. [15] [16] [17] In particular, analysis in a sample of 345 multiplex families from the Autism Genetics Resource Exchange (AGRE) repository 18 revealed a logarithm of the odds (LOD) score of 2.8 on Chromosome 17. 15 When those families were stratified into those with only affected males and analyzed separately, the linkage signal increased to 4.3, 19 whereas for those families containing affected females, the LOD score was essentially zero. This differential linkage pattern was replicated at the same Chromosome 17 locus in an independent AGRE sample of 109 affected sibling pairs. 17 Stratification was achieved by sexes of the affecteds in the family, rather than the sex of the individual child. The reasoning was that affected males in a family are more likely to share male-specific ASD alleles than those from mixed male and female-affected families. These linkage studies were followed by a targeted association study in a subset of 284 parent/affected male child trios from the AGRE families. 20 A total of 1975 SNPs across the Chromosome 17-linked region were spaced more densely than what is typically seen in a GWAS. The strongest association signal was observed for five SNPs in the calcium channel, voltage-dependent, T-type, alpha 1G-subunit gene.
In contrast, the analyses reported here were conducted to search genomewide for G and/or sexspecific G in ASD in families with only affected males in contrast with those with affected females. Joint analyses were conducted to boost the statistical power, as suggested by Kraft et al., 3 and the case/ pseudocontrol approach 6, 7 was used to implement these analyses.
Materials and methods

Study sample and SNP selection
The members of 990 nuclear families ascertained for two or more children with ASD from the AGRE repository were genotyped for the Illumina HumanHap 550 BeadChip SNPs, at the Children's Hospital of Philadelphia. The criteria for family ascertainment are provided in detail on the AGRE website, and with appropriate permissions, these data are available to interested investigators for analysis. Two criteria were used to select those families from the 990 nuclear families that were suitable for the current analyses. The first required families to have two ASD-affected siblings as identified by the Autism Diagnostic Instrument Revised. 21 The second required that both parents and at least one affected child to be genotyped.
The genotypes of 531,689 SNPs for the 990 AGRE families were stored using the PLINK 22 software. For this study, after families were selected, these SNPs were first filtered by removing those with a minor allele frequency < 0.05, Hardy-Weinberg equilibrium with P < 0.0001, or Mendelian errors at a rate of greater than 1.0%, leaving 483,075 for analysis. Following this, families with more than 5% Mendelian errors were removed.
Statistical methods: case/pseudocontrol approach and joint tests of G with G Â F Briefly, for each tested G, three 'pseudocontrol' genotypes that are derived from the possible combinations of untransmitted alleles from heterozygous parents, and these are generated for each affected offspring. For two parents having genotypes ab and cd, if their affected child receives alleles b and d, they will generate 'pseudocontrols' having genotypes ac, ad and bc. Each affected child case and its 'pseudocontrols' compose a 1:3 matched set, where the F status of the 'pseudocontrols' is set to be the same as the F status of their corresponding case. For a family with m-affected children, the family is broken into m groups, each composed of the case and its three matching 'pseudocontrols'. The case/pseudocontrol analysis is modeled through conditional logistic regression, where the likelihood is conditioned on the specific genotypes of the parents, which limits the alleles that can be inherited by the affected child. The power to detect G and G Â F is contingent upon the sample size, the prevalence of F, the frequency of G, its effect size and that of G Â F. The latter effect is reflected by the difference in allele frequencies between the cases and 'pseudocontrols' contingent upon F.
This approach is parametrized by letting p denote the probability of developing the trait. A linear relationship is modeled between p and G, F and
where b 0 denotes an intercept, and b G , b F and b G Â F denote the regression parameters for G, F and G Â F, respectively. X G is a count of the transmissions of the allele being tested when conditioned on the parental genotypes, and X F is coded as one or zero to indicate the presence or absence of F for both the case and the 'pseudocontrols' within a set. The log-likelihood function is stratified for each matched case/pseudocontrol family set and then summed across them. Under this design, b F cannot be estimated, as F does not vary within each family, so we can only test whether G and G Â F are significant. For the multiplex families, Cordell et al. 24 applied a robust variancecovariance estimator (the Huber-White sandwich estimator 23 ) to adjust for the correlation among the siblings within the same family.
The joint test sets b G = 0 and b G Â F = 0 under the null hypothesis. The test statistic is distributed as w 2 2 , and a significant joint P-value implies that either G is associated with the trait or there is a G Â F, which reflects a differential association of G with the disorder conditioned upon the value of F, or both. The test is calculated based on a Wald statistic with robust variance-covariance estimates. This method has been implemented using the R 2.7 software (http://www.r-project.org/).
The analyses were conducted on 548 nuclear families comprised of 2236 individuals. In all, 61% (332) of the families had only male ASD-affected children, and 96% had two or more genotypedaffected children. The level of significance for the joint P-values, a B , was set at 5EÀ08. 25, 26 The significant results were interpreted by analyzing them using the FBAT software. 5 That algorithm tests whether the transmission ratio differs from the expected 50:50, correcting the correlation for multiple siblings in families using a robust variance-covariance estimator.
Results
Results are illustrated in Figure 1 , which presents a plot of the Àlog 10 transformed joint P-values of the joint tests on the vertical axis versus the basepairs within chromosomes along the horizontal axis. The horizontal line indicates the Bonferroni corrected level of significance for the number of SNPs tested. Analyses revealed two SNPs with P-values exceeding genomewide significance. Both SNPs are intronic to known genes. For these SNPs, Table 1 gives the name of the gene where the associated SNP resides, its reference sequence number, its distance in basepairs from the telomere, its chromosome band, its alleles and the frequency of its minor allele. This information is followed by the joint P-value, where the level of significance reflects an allelic association and/or a difference in the transmission frequencies between the ASD families with only affected males versus those with affected females. To help interpret these results, the FBAT software 5 was used to conduct association analyses on the raw data that did not include 'pseudocontrols'. The first FBAT column reports the P-value for the unstratified sample, followed by a column with the transmission results for families with only affected males (MO) and one reporting the same information for the families containing affected females (FC).
The first associated SNP rs6683048 is within an intron of the Ryandine Receptor 2 gene (RyR2) that is involved in calcium channel activation.
27,28
RyR2 produces a protein that is part of a family of ryanodine receptors that form channels to transport positively charged calcium ions within cells. These channels are embedded in the outer membrane of the endoplasmic reticulum, which acts as a storage center for calcium ions, and the RyR2 channel controls the flow of calcium ions out of the endoplasmic reticulum. The gene is expressed in a wide variety of tissues including brain, muscle, heart and placenta. For the associated SNP, the major allele, G, is transmitted 111 times out of the 151 possibilities in the MO families (74%) and 85 out of 129 opportunities in the FC families (66%). Although the transmissions of these two sets of families combine to produce a very significant FBAT P-value of 2.3EÀ09, the joint P-value of 3.9EÀ11 provides stronger evidence of the association. These results illustrate that the significant joint P-value is primarily the result of an overtransmission of the G allele in MO and FC families where the ratio of transmissions of G to nontransmissions differs between them, but is not significantly different.
The second associated SNP, rs1740138, is within an intron of the uridine phosphorylase 2 gene (UPP2), which is involved in nucleotide energy metabolism, and is expressed in kidney, brain and liver. Here, the major allele, T, is associated with ASD, and the P-value, 2.3EÀ09, also reaches genomewide significance. This allele is also overtransmitted in both the MO and FC families. It would not have been detected using the genomewide level of significance, if a parameter for sex differences was not included in the analysis.
Coincidentally, for both genes, the SNPs in Table 1 are the only ones genotyped that are associated with ASD in this sample. To illustrate, Figure 2 presents plots of the Àlog 10 transformed P-values along the vertical axis for each of these genes along the horizontal axis. Their exons are indicated in bold lines along the horizontal axis. This result is consistent with the fact that neither SNP is in pairwise linkage disequilibrium with any other SNPs in the Illumina panel. Figure 3 is a Q/Q plot of the expected versus observed quantiles of the joint P-values for the 483,075 SNPs tested. It provides strong support for the positive signals observed at the genomewide level of significance and indicates that there may be additional associations that this sample does not provide adequate power to detect with the genomewide level of significance used. We examined possible sources of bias that could inflate the Type 1 statistical error. First, the SNPs with P < 0.05 were examined for evidence of genotyping error, which can lead to spurious associations, and those that were questionable were removed. Population stratification or cryptic relatedness in the sample are not of concern, as family-based association studies are not vulnerable to these factors because the transmitted and nontransmitted alleles derive from the same parent as the transmitted alleles and are thus matched for ethnic differences and degrees of relationship. Cordell et al., 29 who developed the case/pseudocontrol approach, conducted simulation studies of 1000 case/parents trios to assess the Type 1 error, and found the expected 5% rate. The nonindependence of the siblings within the multiplex families is accounted for by using the Huber-White sandwich estimator. 23, 24 Finally, lambda is 1.02, indicating that there is no systematic inflation of association statistics above their nominal levels. Thus, we view the Q/Q plot as reflecting the two significantly associated SNPs, which are clearly separated from the other points in the plot. In addition, the top 50-100 points above the expected line may reflect additional genetic contributors to ASD, which we lack the power to detect with this study sample.
Discussion
This study reveals two SNP associations exceeding genomewide significance and highlighting two ASD risk genes for deeper investigations. Both genes exhibit previous connections to ASD. The first, RyR2, is biologically plausible because similar defects in other calcium channel genes have also been associated with ASD. RyR2 has been implicated primarily in several disorders involving calcium channel dysregulation in heart muscle, and greater than 70 mutations in this gene have been found to cause Type I catecholaminergic polymorphic ventricular tachycardia. 30, 31 However, the gene is also expressed in brain, and similar calcium channel defects have been identified in a rare Mendelian genetic condition, Timothy Syndrome. 32, 33 The disorder is caused by a mutation in the gene encoding the calcium channel Ca v 1.2 a subunit. Fewer than 20 people with Timothy Syndrome have been reported worldwide. The mutations cause delayed channel closing and increased cellular excitability, and the most salient feature of Timothy Syndrome is a long QT. However, although the probands have been identified by heart dysregulation symptoms, 80% of the affected children also have impaired communication and socialization skills, and delayed development of speech and language, all core features of ASD. Other nervous system abnormalities, including intellectual disability and seizures, can also occur. Thus, it is very plausible that common variants in this and related calcium channel genes such as RyR2 predispose to ASD.
A different rare calcium channel defect with a mutation in a calcium channel gene encoding for Cav1.4 L-type calcium channel, results in a retinal disorder and visual impairments. The symptoms are more severe in male family members, and five of these affected males exhibit intellectual disability, with three having ASD. 34 For a more complete discussion of the biology of calcium channel defects and ASD, please see Krey and Dolmetsch. 35 Their review reports specific mutations in individual genes that have been found to be seen with both syndromic and nonsyndromic forms of ASD. The review provides an extensive summary of calcium channel defects and indicates how they could lead to ASD during development. In a very recent report, Palmieri et al., 36 provide evidence of altered calcium homeostasis in ASD that has been generated by biochemical studies.
As the ongoing GWAS and sequencing studies reveal more ASD risk variants, the implicated genes may be tied to rare Mendelian disorders that exhibit features of ASD as is seen here. Using the opposite study design, one could identify genes contributing to Mendelian disorders with features of ASD and evaluate common variants for associations with it. For example, association analyses of common SNPs in the Abelson helper integration site 1 gene that causes Joubert Syndrome Type 3, which has features of ASD, are also associated with ASD. 37 Perhaps the most significant support for the role of calcium channel genes in idiopathic ASD comes from the study of 1975 SNPs across Chromosome 17 in 284 parent affected male child AGRE trios. The strongest association signal in this region that shows linkage primarily in males was observed for five SNPs in the Calcium channel, voltage-dependent, T-type, alpha 1G-subunit gene. 20 The second associated gene, UPP2, has been highlighted for ASD before by linkage and targeted association studies. 38 UPP2 is in a Chromosome 2q region that has been linked to ASD in several independent study samples of nuclear families [39] [40] [41] and by homozygosity mapping in larger consanguineous pedigrees. 42 In an International Molecular Genetic Study of Autism Sample Consortium sample of 559 individuals from nuclear families having 126 individuals affected with ASD, dense association testing of 2860 SNPs across the 2q23.3-q32.3-linked region revealed an association for two of the three SNPs that were tested in UPP2 (P < 0.00097). 38 Although those analyses also revealed a UPP2 deletion that removed two coding exons in an affected child, follow-up work did not implicate the deletion in ASD. The biology of this gene and its possible connection to ASD is less clear than that of RyR2.
The identification of genomewide significant associations for two SNPs also highlights the feasibility and statistical power of genomewide joint tests of association in multiplex families. The primary study design for most GWAS has been a comparison of SNP allele frequencies in case and control samples. Joint tests are straightforward in such samples, and the successful application of this approach depends upon the availability of data regarding relevant F. As with ASD, the prevalences of many neurobehavioral disorders and traits show a sex bias. For example, both Schizophrenia and Attention Deficit Hyperactivity Disorder have a higher incidence in males. GWAS data could easily be analyzed by joint tests using the same approach applied here. The epidemiology of a disorder under analysis can suggest relevant F. Currently, there is a strong interest in chemical exposure as an F for ASD. If relevant exposure information becomes available in a GWAS sample, this approach could reveal additional gene observations as well as implicate the chemicals under analysis.
In this analysis, we have demonstrated how one can use joint tests in family panels with GWAS data. This can provide additional statistical power to the samples of parent/child trios and affected sibling-pair samples ascertained for linkage studies. The current focus on genetic sequencing to identify rare predisposing variants is likely to contribute to our understanding of the etiologies of genetically complex neurobehavioral traits such as ASD, but approaches to increase statistical power, such as this one, on available GWAS data, which is likely to become more readily available in the future, can also reveal important genetic and environmental factors. 43 
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